Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial

Authors: Morgan, Todd M. ^{a, ⁎}, Daignault-Newton, Stephanie ^a, Spratt, Daniel E. ^{a, b}, Dunn, Rodney L. ^a, Singhal, Udit ^a, Okoth, Linda A. ^a, Feng, Felix Y. ^c, Johnson, Anna M. ^a, Lane, Brian R. ^d, Linsell, Susan ^a, Ghani, Khurshid R. ^a, Montie, James E. ^a, Mehra, Rohit ^a, Hollenbeck, Brent K. ^a, Maatman, Thomas ^e, Wojno, Kirk ^f, Burks, Frank N. ^f, Bekong, Daniel ^a, Curry, Jon ^g, Rodriguez, Paul ^h, Kleer, Eduardo ⁱ, Sarle, Richard ^j, Miller, David C. ^a, Cher, Michael L. ^k

Source: In European Urology February 2025 87(2):228-237

Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)

Authors: Allaf, Mohamad, Andriole, Gerald, Avery, Ryan J., Avril, Norbert, Barker, Helen, Belkoff, Laurence, Budäus, Lars, Cher, Michael L., Chisholm, Diane, Covington, Matthew F., Cox, Ian, Ferrandino, Michael, Fleming, Mark T., Franceschi, Dinko, Gardiner, Peter, Gartrell, Benjamin, Gauden, David, Hasa, Ergela, Hermsen, Rick, Horn, Thomas, Iranpour, Pooya, Jacene, Heather, Jayaratna, Isuru, Joshi, Shreyas S., Kay, Matthew, Kostakoglu, Lale, Kuo, Phillip, Lavely, William, Lokuta, Mary, Lowentritt, Benjamin, Miller, Matthew P., Nix, Jeffrey W., Ogan, Kenneth, Penny, Ross, Piert, Morand, Purysko, Andrei, Ravizzini, Gregory, Saltzstein, Daniel, Savir-Baruch, Bital, Siegel, Barry A., Steuber, Thomas, Twardowski, Przemyslaw, Uchio, Edward, Ulaner, Gary A., Wixom, Jenna M., Yoo, Don, Zukotynski, Katherine, Surasi, Devaki Shilpa, Eiber, Matthias, Maurer, Tobias, Preston, Mark A., Helfand, Brian T., Josephson, David, Tewari, Ashutosh K., Somford, Diederik M., Rais-Bahrami, Soroush, Koontz, Bridget F., Bostrom, Peter J., Chau, Albert, Davis, Phillip, Schuster, David M., Chapin, Brian F.

Source: In European Urology October 2023 84(4):361-370

Practice-Level Variation in the Decision to Biopsy Prostate Imaging-Reporting and Data System 3 Lesions in Favorable-Risk Prostate Cancer Patients

Authors: Versalle, Derek, Qi, Ji, Noyes, Sabrina L., Moriarity, Andrew, George, Arvin, Cher, Michael L., Lane, Brian R.

Source: In Urology June 2022 164:191-196

Association of lymph node yield with overall survival in patients with pathologically node negative prostate cancer

Authors: Ginsburg, Kevin B., Pressprich, Mark F., Wurst, Hallie A., Cher, Michael L.

Source: In Current Problems in Cancer December 2021 45(6)

Urologists’ Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients

Authors: Xu, Jinping, Bock, Cathryn, Janisse, James, Schwartz, Kendra L., Triest, Jeffrey, Cher, Michael L., Goodman, Michael

Source: In Urology September 2021 155:83-90

Association of Surgical Delay and Overall Survival in Patients With T2 Renal Masses: Implications for Critical Clinical Decision-making During the COVID-19 Pandemic

Authors: Ginsburg, Kevin B., Curtis, Gannon L., Patel, Devin N., Chen, Wen Min, Strother, Marshall C., Kutikov, Alexander, Derweesh, Ithaar H., Cher, Michael L.

Source: In Urology January 2021 147:50-56

Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance

Authors: Ginsburg, Kevin B, Jacobs, Jesse C, Qi, Ji, Kaye, Deborah R, Eggly, Susan S, Linsell, Susan M, Auffenberg, Gregory B, George, Arvin K, Montie, James E, Cher, Michael L

Source: In Urology January 2021 147:213-222

Pelvic lymph node dissection at robot-assisted radical prostatectomy: Assessing utilization and nodal metastases within a statewide quality improvement consortium

Authors: Lescay, Hernan, Abdollah, Firas, Cher, Michael L., Qi, Ji, Linsell, Susan, Miller, David C., Montie, James E., Peabody, James, Kaffenberger, Samuel, Morgan, Todd, Loeb, Aram, Lane, Brian R.

Source: In Urologic Oncology: Seminars and Original Investigations April 2020 38(4):198-203

National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms

Authors: Modi, Parth K., Kaufman, Samuel R., Qi, Ji, Lane, Brian R., Cher, Michael L., Miller, David C., Hollenbeck, Brent K., Shahinian, Vahakn B., Dupree, James M.

Source: In Urology October 2018 120:96-102

Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer

Authors: Kaye, Deborah R. ^*, Qi, Ji, Morgan, Todd M., Linsell, Susan, Lane, Brian R., Montie, James E., Cher, Michael L., Miller, David C.

Source: In Urology August 2018 118:127-133

Maspin Expression Inhibits Osteolysis, Tumor Growth, and Angiogenesis in a Model of Prostate Cancer Bone Metastasis

Authors: Cher, Michael L., Biliran,, Hector R., Bhagat, Sunita, Meng, Yonghong, Che, Mingxin, Lockett, Jaron, Abrams, Judith, Fridman, Rafael, Zachareas, Michael, Sheng, Shijie

Source: Proceedings of the National Academy of Sciences of the United States of America, 2003 Jun . 100(13), 7847-7852.

Access URL: https://www.jstor.org/stable/3139835

Establishment of a Web-based System for Collection of Patient-reported Outcomes After Radical Prostatectomy in a Statewide Quality Improvement Collaborative

Authors: Lucas, Steven M. ^*, Kim, Tae-Kyung, Ghani, Khurshid R., Miller, David C., Linsell, Susan, Starr, Jay, Peabody, James O., Hurley, Patrick, Montie, James, Cher, Michael L.

Source: In Urology September 2017 107:96-102

Appropriateness Criteria for Active Surveillance of Prostate Cancer

Authors: Cher, Michael L., Dhir, Apoorv, Auffenberg, Gregory B., Linsell, Susan, Gao, Yuqing, Rosenberg, Bradley, Jafri, S. Mohammad, Klotz, Laurence, Miller, David C., Ghani, Khurshid R., Bernstein, Steven J., Montie, James E., Lane, Brian R.

Source: In The Journal of Urology January 2017 197(1):67-74

Does Urologist-level Utilization of Active Surveillance for Low-risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses?

Authors: Wang, Michael, Wittenberg, Sophie, Cher, Michael L., Van Til, Monica, Ferrante, Stephanie, Mirza, Mahin, Johnson, Anna, Semerjian, Alice, George, Arvin, Rogers, Craig, Wilder, Samantha, Sarle, Richard, Ghani, Khurshid R., Lane, Brian, Ginsburg, Kevin B.

Source: In European Urology February 2024 85(2):101-104

Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS).

Authors: Jinping Xu, Bock, Cathryn H., Janisse, James, Woo, Justin, Cher, Michael L., Ginsburg, Kevin, Yacoub, Rami, Goodman, Michael

Source: Cancer (0008543X); 5/15/2024, Vol. 130 Issue 10, p1797-1806, 10p

Subject Terms: PROSTATE cancer, PROSTATE cancer patients, WATCHFUL waiting, CANCER treatment, PSYCHOLOGICAL factors, BLACK men

Geographic Terms: DETROIT (Mich.), GEORGIA

MUSIC: Patterns of Care in the Radiographic Staging of Men with Newly Diagnosed Low Risk Prostate Cancer

Authors: Ross, Ishai, Womble, Paul, Ye, Jun, Linsell, Susan, Montie, James E., Miller, David C., Cher, Michael L.

Source: In The Journal of Urology April 2015 193(4):1159-1162

Should all prostate needle biopsy Gleason score 4 + 4 = 8 prostate cancers be high risk? Implications for shared decision-making and patient counselling

Authors: Ginsburg, Kevin, Cole, Adam I., Silverman, Michael E., Livingstone, Joan, Smith, Daryn W., Heilbrun, Lance K., Shi, Dongping, Mehra, Rohit, Sakr, Wael A., Morgan, Todd M., Cher, Michael L.

Source: In Urologic Oncology: Seminars and Original Investigations March 2020 38(3):78-78

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth.

Authors: Govindarajan, Barani, Sbrissa, Diego, Pressprich, Mark, Kim, Seongho, Rishi, Arun K., Vaishampayan, Ulka, Cher, Michael L., Chinni, Sreenivasa R.

Source: Scientific Reports; 11/23/2023, Vol. 13 Issue 1, p1-13, 13p

Subject Terms: ADAPTOR proteins, CXCR4 receptors, PROSTATE cancer, BONE growth, TUMOR growth, ANDROGEN receptors

Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillance.

Authors: Wang, Michael, Lange, Andrew, Perlman, David, Qi, Ji, George, Arvin K., Ferrante, Stephanie, Semerjian, Alice, Sarle, Richard, Cher, Michael L., Ginsburg, Kevin B.

Source: Prostate; Sep2023, Vol. 83 Issue 12, p1141-1149, 9p

PTEN Regulates PDGF Ligand Switch for β-PDGFR Signaling in Prostate Cancer

Authors: Conley-LaComb, M. Katie, Huang, Wei, Wang, Shihua, Shi, Dongping, Jung, Young Suk, Najy, Abdo, Fridman, Rafael, Bonfil, R. Daniel, Cher, Michael L., Chen, Yong Q., Kim, Hyeong-Reh Choi

Source: In The American Journal of Pathology March 2012 180(3):1017-1027